1 – 20 of 959
- show: 20
- |
- sort: year (new to old)
- |
- Export
- 2024
- Incidence and radiotherapy treatment patterns of complicated bone metastases (2024) JOURNAL OF BONE ONCOLOGY. 44.
- PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial (2024) EUROPEAN UROLOGY ONCOLOGY.
- Sexual health in Belgian cervical cancer survivors : an exploratory qualitative study (2024) QUALITY OF LIFE RESEARCH.
- Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy : real-world data from the E2-RADIatE OligoCare cohort (2024) CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 45.
- Moderate hypofractionated radiotherapy for prostate cancer : 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial (2024) RADIOTHERAPY AND ONCOLOGY. 193.
- VIMAP-trial : vulvar cancer intra-operative margin assessment using PET-CT (2024) ESGO 2024 Congress, Abstracts.
- Epidemiology and survival of adult-type diffuse glioma in Belgium during the molecular era (2024) NEURO-ONCOLOGY. 26(1). p.191-202
- An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care (2024) PLOS ONE. 19(1).
- Peripheral blood lymphocytes differ in DNA damage response after exposure to X-rays with different physical properties (2024) INTERNATIONAL JOURNAL OF RADIATION BIOLOGY. p.1-12
- Stereotactic body and conventional radiotherapy for painful bone metastases : a systematic review and meta-analysis (2024) JAMA NETWORK OPEN. 7(2).
- Multiregion sampling of de novo metastatic prostate cancer reveals complex polyclonality and augments clinical genotyping (2024) NATURE CANCER. 5(1). p.5-7
- Performance of MRI for detection of ≥pT1b disease in local staging of endometrial cancer (2024) CANCERS. 16(6).
- Identification and validation of extracellular vesicle reference genes for the normalization of RT‐qPCR data (2024) JOURNAL OF EXTRACELLULAR VESICLES. 13(4).
- The efficacy and safety of metastasis-directed therapy in patients with prostate cancer : a systematic review and meta-analysis of prospective studies (2024) EUROPEAN UROLOGY. 85(2). p.125-138
- 2023
- Detection of biomarkers to reduce radiation-induced toxicities and improve clinical outcomes, with emphasis on the role of unintended dose (2023)
- Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy (2023) JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS. 24(8).
- Microbiome and metabolome dynamics during radiotherapy for prostate cancer (2023) RADIOTHERAPY AND ONCOLOGY. 189.
- Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial (2023) JAMA ONCOLOGY. 9(9). p.1205-1213
- Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy : the Lung PLUS study (2023) FRONTIERS IN ONCOLOGY. 13.
- Developing time-driven activity-based costing at the national level to support policy recommendations for radiation oncology in Belgium (2023) JOURNAL OF ACCOUNTING AND PUBLIC POLICY. 42(1).